{"entity":{"type":"insider","cik":"0001777962","url":"/insider/0001777962","json_url":"/insider/0001777962.json","name":"Nijhawan Pardeep","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":23,"first":"2020-03-19","last":"2026-03-10","span_basis":"filed_date"},"name_variants":[{"name":"Nijhawan Pardeep","source":"filing","n_filings":23,"first_seen":"2020-03-19","last_seen":"2026-03-10"}],"transactions":[{"id":5883443,"accession":"0001171843-26-001463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-26-001463","line_url":"/filing/0001171843-26-001463#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":"0001777962","owner_name":"Nijhawan Pardeep","owner_display_name":"Nijhawan Pardeep","owner_url":"/insider/0001777962","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.5989,"price_display":"6.60","price_state":"stated","total_value":6598.9,"total_display":"6,598.90","total_whole":"6,599","shares_owned_after":628813.0,"shares_owned_after_display":"628,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-10","scope":"insider"},{"id":5835958,"accession":"0001171843-26-001390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-26-001390","line_url":"/filing/0001171843-26-001390#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":"0001777962","owner_name":"Nijhawan Pardeep","owner_display_name":"Nijhawan Pardeep","owner_url":"/insider/0001777962","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":39000.0,"total_display":"39,000.00","total_whole":"39,000","shares_owned_after":402702.0,"shares_owned_after_display":"402,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":6193808,"accession":"0001171843-26-001370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-26-001370","line_url":"/filing/0001171843-26-001370#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":"0001777962","owner_name":"Nijhawan Pardeep","owner_display_name":"Nijhawan Pardeep","owner_url":"/insider/0001777962","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.256,"price_display":"4.26","price_state":"stated","total_value":42560.0,"total_display":"42,560.00","total_whole":"42,560","shares_owned_after":392702.0,"shares_owned_after_display":"392,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-05","scope":"insider"},{"id":5769977,"accession":"0001171843-26-001329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-26-001329","line_url":"/filing/0001171843-26-001329#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":"0001777962","owner_name":"Nijhawan Pardeep","owner_display_name":"Nijhawan Pardeep","owner_url":"/insider/0001777962","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.63,"price_display":"3.63","price_state":"stated","total_value":36300.0,"total_display":"36,300.00","total_whole":"36,300","shares_owned_after":382702.0,"shares_owned_after_display":"382,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":5904109,"accession":"0001171843-26-001302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001171843-26-001302","line_url":"/filing/0001171843-26-001302","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":"0001777962","owner_name":"Nijhawan Pardeep","owner_display_name":"Nijhawan Pardeep","owner_url":"/insider/0001777962","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.0932,"price_display":"2.09","price_state":"stated","total_value":6279.6,"total_display":"6,279.60","total_whole":"6,280","shares_owned_after":627813.0,"shares_owned_after_display":"627,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider","n_lines":2},{"id":6000346,"accession":"0001171843-26-001267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001171843-26-001267","line_url":"/filing/0001171843-26-001267#line-2","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":"0001777962","owner_name":"Nijhawan Pardeep","owner_display_name":"Nijhawan Pardeep","owner_url":"/insider/0001777962","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":2.2232,"price_display":"2.22","price_state":"stated","total_value":66696.0,"total_display":"66,696.00","total_whole":"66,696","shares_owned_after":371702.0,"shares_owned_after_display":"371,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":6000343,"accession":"0001171843-26-001267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-26-001267","line_url":"/filing/0001171843-26-001267#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":"0001777962","owner_name":"Nijhawan Pardeep","owner_display_name":"Nijhawan Pardeep","owner_url":"/insider/0001777962","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20571.0,"shares_display":"20,571","price_per_share":1.5789,"price_display":"1.58","price_state":"stated","total_value":32479.5519,"total_display":"32,479.55","total_whole":"32,480","shares_owned_after":615797.0,"shares_owned_after_display":"615,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-03-02","scope":"insider"},{"id":2097913,"accession":"0001654954-24-003606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-24-003606","line_url":"/filing/0001654954-24-003606#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","total_whole":"20,000","shares_owned_after":341702.0,"shares_owned_after_display":"341,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-25","scope":"insider"},{"id":6135752,"accession":"0001654954-22-009259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-009259","line_url":"/filing/0001654954-22-009259#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.6039,"price_display":"1.60","price_state":"stated","total_value":32078.0,"total_display":"32,078.00","total_whole":"32,078","shares_owned_after":594812.0,"shares_owned_after_display":"594,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-30","filed_date":"2022-07-05","scope":"insider"},{"id":6311476,"accession":"0001654954-22-007684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-007684","line_url":"/filing/0001654954-22-007684#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.9198,"price_display":"1.92","price_state":"stated","total_value":9599.0,"total_display":"9,599.00","total_whole":"9,599","shares_owned_after":574812.0,"shares_owned_after_display":"574,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":6763869,"accession":"0001654954-22-007509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-007509","line_url":"/filing/0001654954-22-007509#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.7998,"price_display":"1.80","price_state":"stated","total_value":3599.6,"total_display":"3,599.60","total_whole":"3,600","shares_owned_after":569812.0,"shares_owned_after_display":"569,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":6763841,"accession":"0001654954-22-004413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-004413","line_url":"/filing/0001654954-22-004413#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.9858,"price_display":"2.99","price_state":"stated","total_value":5971.6,"total_display":"5,971.60","total_whole":"5,972","shares_owned_after":567812.0,"shares_owned_after_display":"567,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-31","filed_date":"2022-04-01","scope":"insider"},{"id":6831206,"accession":"0001654954-22-004245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-004245","line_url":"/filing/0001654954-22-004245#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.0491,"price_display":"3.05","price_state":"stated","total_value":6098.2,"total_display":"6,098.20","total_whole":"6,098","shares_owned_after":565812.0,"shares_owned_after_display":"565,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-30","filed_date":"2022-03-31","scope":"insider"},{"id":6581404,"accession":"0001654954-22-004118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-004118","line_url":"/filing/0001654954-22-004118#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.0168,"price_display":"3.02","price_state":"stated","total_value":6033.6,"total_display":"6,033.60","total_whole":"6,034","shares_owned_after":563812.0,"shares_owned_after_display":"563,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-30","scope":"insider"},{"id":6334698,"accession":"0001654954-22-003483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-003483","line_url":"/filing/0001654954-22-003483#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.8496,"price_display":"3.85","price_state":"stated","total_value":7699.2,"total_display":"7,699.20","total_whole":"7,699","shares_owned_after":561812.0,"shares_owned_after_display":"561,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-21","scope":"insider"},{"id":6257204,"accession":"0001654954-22-003409","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001654954-22-003409","line_url":"/filing/0001654954-22-003409","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.2611813,"price_display":"3.26","price_state":"stated","total_value":6522.3626,"total_display":"6,522.36","total_whole":"6,522","shares_owned_after":559812.0,"shares_owned_after_display":"559,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-18","scope":"insider","n_lines":2},{"id":6706727,"accession":"0001654954-22-003224","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-003224","line_url":"/filing/0001654954-22-003224#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.799,"price_display":"2.80","price_state":"stated","total_value":5598.0,"total_display":"5,598.00","total_whole":"5,598","shares_owned_after":557812.0,"shares_owned_after_display":"557,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-16","scope":"insider"},{"id":6524980,"accession":"0001654954-22-003095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001654954-22-003095","line_url":"/filing/0001654954-22-003095","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":3.0931571428571427,"price_display":"3.09","price_state":"stated","total_value":21652.1,"total_display":"21,652.10","total_whole":"21,652","shares_owned_after":555812.0,"shares_owned_after_display":"555,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider","n_lines":2},{"id":6257198,"accession":"0001654954-22-002850","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-22-002850","line_url":"/filing/0001654954-22-002850#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":3.0464,"price_display":"3.05","price_state":"stated","total_value":4569.6,"total_display":"4,569.60","total_whole":"4,570","shares_owned_after":548812.0,"shares_owned_after_display":"548,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-09","filed_date":"2022-03-10","scope":"insider"},{"id":5444091,"accession":"0001654954-21-003334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-21-003334","line_url":"/filing/0001654954-21-003334#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":15750.0,"total_display":"15,750.00","total_whole":"15,750","shares_owned_after":545312.0,"shares_owned_after_display":"545,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-25","filed_date":"2021-03-26","scope":"insider"},{"id":5383209,"accession":"0001654954-21-003274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-21-003274","line_url":"/filing/0001654954-21-003274#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":25800.0,"total_display":"25,800.00","total_whole":"25,800","shares_owned_after":542312.0,"shares_owned_after_display":"542,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-24","filed_date":"2021-03-25","scope":"insider"},{"id":3163721,"accession":"0001654954-20-006029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-20-006029","line_url":"/filing/0001654954-20-006029#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.9797,"price_display":"2.98","price_state":"stated","total_value":8939.1,"total_display":"8,939.10","total_whole":"8,939","shares_owned_after":2124024.0,"shares_owned_after_display":"2,124,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-28","scope":"insider"},{"id":4194848,"accession":"0001654954-21-003384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-21-003384","line_url":"/filing/0001654954-21-003384#line-1","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.23,"price_display":"5.23","price_state":"stated","total_value":10460.0,"total_display":"10,460.00","total_whole":"10,460","shares_owned_after":547312.0,"shares_owned_after_display":"547,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-29","filed_date":"2021-03-29","scope":"insider"},{"id":2158962,"accession":"0001654954-20-002851","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001654954-20-002851","line_url":"/filing/0001654954-20-002851","is_derivative":false,"issuer_cik":"0001540159","issuer_name":"Edesa Biotech, Inc.","issuer_ticker":"EDSA","issuer_name_source":null,"issuer_url":"/issuer/0001540159","owner_cik":null,"owner_name":"Nijhawan Pardeep; Pardeep Nijhawan Medicine Professional Corp","owner_display_name":"Nijhawan Pardeep","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.87462,"price_display":"1.87","price_state":"stated","total_value":9373.1,"total_display":"9,373.10","total_whole":"9,373","shares_owned_after":2119024.0,"shares_owned_after_display":"2,119,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001540159","name":"Edesa Biotech, Inc.","url":"/issuer/0001540159","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":23,"first_seen":"2020-03-19","last_seen":"2026-03-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001777962","retrieved_at":"2026-08-22T07:58:21+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}